Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
COEP Coeptis Therapeutics Holdings Inc
- Stocks
- Healthcare
- NASDAQ: COEP
Price (delayed)
$7.72
Market cap
$27.13M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.16
Enterprise value
$24.9M
Highlights
The equity has soared by 103% since the previous quarter
The EPS has soared by 52% YoY and by 9% QoQ
Coeptis Therapeutics Holdings's debt has increased by 46% from the previous quarter but it has decreased by 16% YoY
Key stats
What are the main financial stats of COEP
Market
Valuations
Earnings
Shares outstanding
3.51M
Market cap
$27.13M
Enterprise value
$24.9M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.01
Price to sales (P/S)
377.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
396.01
Revenue
$62,874
Gross profit
$17,718
Operating income
-$11.19M
Net income
-$9.87M
EBIT
-$9.6M
EBITDA
-$8.51M
Free cash flow
-$7.11M
Per share
Balance sheet
Liquidity
EPS
-$5.16
EPS diluted
-$5.16
Free cash flow per share
-$2.31
Book value per share
$1.93
Revenue per share
$0.02
TBVPS
$4.22
Total assets
$13.45M
Total liabilities
$5.99M
Debt
$2.04M
Equity
$6.48M
Working capital
-$1M
Debt to equity
0.31
Current ratio
0.82
Quick ratio
0.76
Net debt/EBITDA
0.26
Margins
Efficiency
Dividend
EBITDA margin
-13,533.6%
Gross margin
28.2%
Net margin
-15,698%
Operating margin
-17,796.1%
Return on assets
-111.2%
Return on equity
-281.1%
Return on invested capital
-229.3%
Return on capital employed
-123.1%
Return on sales
-15,273.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
COEP stock price
How has the Coeptis Therapeutics Holdings stock price performed over time
Intraday
-5.97%
1 week
-10.96%
1 month
-21.3%
1 year
18.95%
YTD
40.36%
QTD
-17.61%
Financial performance
How have Coeptis Therapeutics Holdings's revenue and profit performed over time
Revenue
$62,874
Gross profit
$17,718
Operating income
-$11.19M
Net income
-$9.87M
Gross margin
28.2%
Net margin
-15,698%
Coeptis Therapeutics Holdings's operating income has increased by 37% YoY but it has decreased by 11% from the previous quarter
Price vs fundamentals
How does COEP's price correlate with its fundamentals
Growth
What is Coeptis Therapeutics Holdings's growth rate over time
Valuation
What is Coeptis Therapeutics Holdings stock price valuation
P/E
N/A
P/B
4.01
P/S
377.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
396.01
The EPS has soared by 52% YoY and by 9% QoQ
The equity has soared by 103% since the previous quarter
Efficiency
How efficient is Coeptis Therapeutics Holdings business performance
COEP's return on assets has dropped by 171% year-on-year but it is up by 26% since the previous quarter
The company's return on equity has shrunk by 131% YoY but it has surged by 54% QoQ
Coeptis Therapeutics Holdings's return on invested capital has shrunk by 115% YoY but it has increased by 23% QoQ
Dividends
What is COEP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for COEP.
Financial health
How did Coeptis Therapeutics Holdings financials performed over time
The total assets is 125% greater than the total liabilities
The company's current ratio has surged by 156% YoY
The total assets has surged by 51% since the previous quarter
Coeptis Therapeutics Holdings's debt is 69% less than its equity
COEP's debt to equity has surged by 115% year-on-year but it is down by 30% since the previous quarter
The equity has soared by 103% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.